Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous 5-FU in Recurrent/Metastatic Transitional Cell Carcinoma
NCT00003175Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Dec 1997
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of fluorouracil in transitional cell carcinoma (TCC), sponsored by Medical Research Council. Started Dec 1997; status: completed.
02
Drugs
fluorouracil
03
Conditions
transitional cell carcinoma (TCC)
Beyond the preview
Go deeper on NCT00003175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003175.